APA (7th ed.) Citation

Steinfield, S. R., Stenn, D. F., Chen, H., & Kalisch, B. E. (2025). A Review of the Clinical Progress of CT1812, a Novel Sigma-2 Receptor Antagonist for the Treatment of Alzheimer's Disease. Pharmaceuticals (14248247), 18(5), 659. https://doi.org/10.3390/ph18050659

Chicago Style (17th ed.) Citation

Steinfield, Sara R., Daniel F. Stenn, Helen Chen, and Bettina E. Kalisch. "A Review of the Clinical Progress of CT1812, a Novel Sigma-2 Receptor Antagonist for the Treatment of Alzheimer's Disease." Pharmaceuticals (14248247) 18, no. 5 (2025): 659. https://doi.org/10.3390/ph18050659.

MLA (9th ed.) Citation

Steinfield, Sara R., et al. "A Review of the Clinical Progress of CT1812, a Novel Sigma-2 Receptor Antagonist for the Treatment of Alzheimer's Disease." Pharmaceuticals (14248247), vol. 18, no. 5, 2025, p. 659, https://doi.org/10.3390/ph18050659.